Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Zeiss (company)

Tracked across 13 events · 145 articles · First seen Apr 28, 2025 · Last active Sep 14, 2026

Sentiment
14
Attention
4
Events
13
Relationships
8
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
1 15
Tech
Zeiss (company) introduced the ZEISS VersaXRM 5 Insight, a hybrid 3D X-ray microscope that combines X-ray microscopy and microCT in a single platform. The system is designed to deliver multi-scale imaging, guided workflows, and automated…
Impact: Zeiss (company) is the developer and seller of the VersaXRM 5 Insight, and the launch expands its X-ray microscopy portfolio in materials research, industrial inspection, and life sciences. The product could modestly support its Industrial Quality & Research segment revenue and reinforce its technology leadership.
Sep 14, 2026 · 6 articles
2 50
Tech
Impact: Zeiss (company)'s product, the ZEISS CIRRUS PathFinder, was adopted by Angel Eye and Cataract Centre, demonstrating the continued market penetration and utility of its AI-assisted ophthalmology tools.
Jun 03, 2026 · 7 articles
4 30
Business
Impact: Zeiss (company) is partnering with Vivo for the camera setup in the V70 series, aiming to deliver enhanced imaging capabilities.
Jan 25, 2026 · 27 articles
2 20
Regulatory
Impact: Zeiss (company) is the majority shareholder of Carl Zeiss Meditec. The clearance indirectly benefits Zeiss (company) through its subsidiary's success, but it is not directly involved in the event.
Aug 19, 2026 · 6 articles
2 10
Business
Impact: Florian Leiss previously led strategic initiatives within the Zeiss (company) ecosystem, which ultimately led to the creation of Revolut as an independent spin-out.
Apr 15, 2026 · 6 articles
4 0
Tech
Impact: Zeiss (company) holds approximately 59 percent of Carl Zeiss Meditec AG's shares, benefiting from the success of its subsidiary's medical innovations.
Jun 11, 2026 · 7 articles
2 5
Business
Impact: Zeiss (company) is the majority shareholder of Carl Zeiss Meditec, holding approximately 59% of shares. The product launch indirectly benefits the parent company through its subsidiary's performance.
Jul 20, 2026 · 6 articles
2 35
Business
Impact: Listed as a key player in digital pathology.
Jun 24, 2026 · 8 articles
4 0
Business
Impact: Zeiss (company) is mentioned as a major Brazilian enterprise that Performa IT has a proven track record with, indicating Performa IT's strong market presence.
Apr 10, 2026 · 6 articles
4 0
Business
Impact: Zeiss (company) holds approximately 59% of Carl Zeiss Meditec shares, making it a significant shareholder, but its direct impact on this specific event is indirect.
Jun 17, 2026 · 7 articles
4 20
Business
Impact: Zeiss (company) holds approximately 59% of Carl Zeiss Meditec AG's shares, indicating its indirect involvement and benefit from Carl Zeiss Meditec's strategic moves.
Jun 18, 2026 · 8 articles
4 0
Business
Jan 08, 2026 · 45 articles
2 0
Business
Mar 06, 2026 · 6 articles
90 Zeiss (company) introduced hybrid 3D microscopeZEISS launches VersaXRM 5...
Vivo ↔ Zeiss (company)
Vivo ↔ Zeiss (company)
MediaTek ↔ Zeiss (company)
MediaTek ↔ Zeiss (company)
Walmart — Flipkart ↔ Zeiss (company)
Walmart — Flipkart ↔ Zeiss (company)
India ↔ Zeiss (company)
India ↔ Zeiss (company)
ERGEN INTELLIGENCE
Track Zeiss (company) live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.